NCT06918054RecruitingPhase 4
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Hepatoprotective Measures for Children and Adolescents With Acute Lymphoblastic Leukemia During Induction Chemotherapy
Source: ClinicalTrials.gov · Last updated 9 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- First submitted
- 6 Dec 2024
- Start date
- 17 Nov 2023
- Primary completion date
- May 2025
- Lead sponsor
- Ain Shams University
- NCT number
- NCT06918054
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 42
- From 17 Nov 2023 to the primary completion date, May 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known chronic liver disease.
Who the study is looking for
- Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams
Age in the registry: 2 years to 18 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of medicine Ain shams Research Institute-Clinical Research Center (MASRI-CRC) Coordinator of this site? Confirm its status | Cairo | Egypt | Recruiting |
| Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.